VCYT
VERACYTE, INC. · Healthcare · Market cap $3.7B
Insiders sold $1.4M net in the last 90 days ·6 sellers, 0 buyers· 7 of 7 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 20, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$21.1M
reported sales (SEC code S)
Unique Insiders
11
in the rolling window
Latest filing
Oct 20, 2026
Bhanji Muna
VERACYTE, INC. (VCYT) has 67 SEC Form 4 filings (119 transaction rows) in the rolling window, disclosed by 11 distinct insiders. Most recent filing: Oct 20, 2026.
Inside the rolling window, 11 insiders at VERACYTE, INC. reported no open-market purchases and 35 open-market sales totaling $21.1M. The most active filer is EVP, General Counsel McGuire Annie with 7 filings. Insiders have net sold $11.5M over the trailing 6 months. The most recent open-market filing is a sale of 1,864 shares by Director Bhanji Muna, dated Oct 19, 2026, worth $81K.
- Industry:Medical - Diagnostics & Research
- CEO:Marc Stapley
- Employees:755
- HQ:South San Francisco, CA, US
- IPO:2013-10-29
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Director | Sale | 1,864 | $81K | Oct 20 | +2.8% | SEC ↗ | |
Leite JohnFirst in 4 months | Global Chief Commercial Off | Sale | 4,015 | $161K | Sep 22 | +6.2% | SEC ↗ |
Holstein JensFirst in 10 months | Director | Sale | 5,000 | $205K | Sep 16 | +19.6% | SEC ↗ |
Febbo Phillip G.First in 6 months | Chief Scientific & Med Officer | Sale | 13,110 | $564K | Sep 4 | +8.3% | SEC ↗ |
Chambers RebeccaFirst in 3 months | Chief Financial Officer | Sale | 3,652 | $157K | Sep 4 | +8.3% | SEC ↗ |
McGuire AnnieFirst in 3 months | EVP, General Counsel | Sale | 3,254 | $140K | Sep 4 | +8.3% | SEC ↗ |
Bhanji MunaFirst filing | Director | Sale | 1,864 | $80K | Sep 3 | +3.1% | SEC ↗ |
EASTHAM KARINFirst in 7 months | Director | Sale | 3,729 | $197K | Jun 22 | — | SEC ↗ |
| EVP, General Counsel | Sale | 3,176 | $158K | Jun 5 | — | SEC ↗ | |
Chambers RebeccaFirst in 3 months | Chief Financial Officer | Sale | 3,561 | $177K | Jun 5 | — | SEC ↗ |
Stapley MarcFirst in 3 months | Chief Executive Officer | Sale | 138,051 | $6.9M | Jun 5 | — | SEC ↗ |
Leite JohnFirst in 3 months | Global Chief Commercial Off | Sale | 13,975 | $700K | Jun 5 | — | SEC ↗ |
Wygant JonathanFirst in 7 months | VP, Chief Accounting Officer | Sale | 24,000 | $1.1M | May 27 | — | SEC ↗ |
EPSTEIN ROBERT SFirst filing | Director | Sale | 10,000 | $440K | May 22 | — | SEC ↗ |
| SVP, General Counsel | Sale | 10,204 | $398K | May 8 | — | SEC ↗ | |
Chambers RebeccaFirst in 3 months | Chief Financial Officer | Sale | 18,341 | $663K | Mar 6 | — | SEC ↗ |
| SVP, General Counsel | Sale | 6,658 | $237K | Mar 6 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 45,523 | $1.6M | Mar 6 | — | SEC ↗ | |
Leite JohnFirst in 3 months | Chief Commercial Officer-CLIA | Sale | 5,260 | $185K | Mar 6 | — | SEC ↗ |
Febbo Phillip G.First filing | Chief Scientific & Med Officer | Sale | 13,425 | $485K | Mar 4 | — | SEC ↗ |
| SVP, General Counsel | Sale | 10,739 | $463K | Dec 17 | — | SEC ↗ | |
| Director | Sale | 20,000 | $909K | Dec 8 | — | SEC ↗ | |
| SVP, General Counsel | Sale | 1,422 | $67K | Dec 4 | — | SEC ↗ | |
Stapley MarcFirst filing | Chief Executive Officer | Sale | 7,668 | $361K | Dec 4 | — | SEC ↗ |
| Chief Financial Officer | Sale | 13,278 | $622K | Dec 4 | — | SEC ↗ |
Earnings: last 7 quarters
Congress trading VCYT 14 all-time
- DRep. Gilbert Ray CisnerosPurchase$1,001 - $15,0002026-02-18
- DRep. Gilbert Ray CisnerosOther$1,001 - $15,0002025-11-12
- DRep. Gilbert Ray CisnerosPurchase$1,001 - $15,0002025-06-16
- DRep. Josh S. GottheimerPurchase$1,001 - $15,0002023-10-16
- DRep. Josh S. GottheimerSale$1,001 - $15,0002023-09-15
- DRep. Daniel GoldmanSale$1,001 - $15,0002023-04-10
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does VCYT have?
VERACYTE, INC. (VCYT) has 67 SEC Form 4 filings (119 transaction rows) in the rolling 365-day window, disclosed by 11 distinct insiders. Most recent filing: Oct 20, 2026.
When was the most recent SEC Form 4 filing for VCYT?
The most recent Form 4 filing for VCYT on Tracefour is dated Oct 20, 2026.
Who is the most active insider at VCYT?
The most active SEC Form 4 filer at VCYT in the rolling window is EVP, General Counsel McGuire Annie, with 7 filings.
What is the net insider flow at VCYT over the last 6 months?
Over the trailing 180 days, insiders at VCYT have net sold $11.5M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at VCYT in the current window?
Inside the rolling window, insiders at VCYT bought $0 and sold $21.1M based on SEC Form 4 filings.
Can I get alerts for VCYT insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at VERACYTE, INC. (VCYT). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
VERACYTE, INC. is in the Healthcare sector.